Chronic total occlusions, a true challenge

Original title: Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention. A Report From the NCDR (National Cardiovascular Data Registry). Reference: Emanuel S. Brilakis, et al. JACC Cardiovascular Intervention 2015;8:245-53

Chronic total occlusions (CTO) are present in 20% to 50% of pathological coronary angiograms but, even though this percentage has increased in the past years, PCI is performed in around 4% of this kind of lesions.

This study included 594,510 stable patients; 22,365 of them (3.8%) received CTO PCI. Patients presenting CTO were younger, more frequently men, often with prior infarction, prior PCI and ventricular failure.

Procedural success was lower for CTO (59% vs. 96%; p<0.001), with marked variability in centers and operators. Procedural success was associated to the annual volume of CTO PCIs of operators, 10 being 53%, 62% and 75% (p<0.001). The group requiring vessel revascularization required greater contrast volume and longer fluoroscopy time.

Procedural success also increased with operator experience, 55.5% in 2009 to 61.9% in 2013 (p<0.01). Multivariable analysis associated lower procedural success to age, smoking, previous myocardial infarction, previous CABG, previous peripheral heart disease, right coronary artery CTO target vessel and less operator experience.

Combined events resulted higher in CTO PCIs than in conventional PCIs (1.6% vs. 0.8% p<0.001). More operator experience was associated to a lower events risk.

Conclusion

CTO PCI is not frequent in USA in stable patients and is associated to a lower procedural success and a higher complications rate, compared to outcomes in patients that do not present CTO. Success is associated with patient characteristics and operator experience.

Editorial Comment

When performing CTI success will depend on operator and center. Different studies have shown the benefits of revascularization, especially when it comes to the anterior descending artery.

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation– Argentina

Carlos Fava

Previous article
Next article

More articles by this author

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

Comparison of strategies: NMA of IVUS, OCT, or angiography in complex lesions

Percutaneous coronary intervention (PCI) in complex lesions continues to represent a technical challenge in contemporary interventional cardiology. Angiography, although it remains the most widely...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

FFR Assessment for the Selection of Hypertensive Patients Who Benefit from Renal Stenting

Atherosclerotic renal artery stenosis (ARAS) represents one of the main causes of secondary hypertension (HTN) and is associated with a higher risk of renal...